EMA
approval
· 2026-03-13
EMA Authorised: Arsenic trioxide Accord (arsenic trioxide) — Accord Healthcare S.L.U.
Summary
The European Medicines Agency authorised Arsenic trioxide Accord for the treatment of acute promyelocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Leukemia, Promyelocytic, Acute. MAH: Accord Healthcare S.L.U.. Decision date: 13/03/2026